https://www.selleckchem.com/products/tng-462.html
39 ± 2.68years, and femoral components had been followed for an average of 21.6 ± 4.06years since the time of implantation. Average HHS of the patients were 53 before revision surgery and 81.9 at the last follow-up ( 0.001). The 10-year survival rate of patients who underwent revision in the femoral component was 100%, whereas their 15-year survival rate was 93.3%. None of the acetabular components required revision. Isolated revision of acetabular component may be considered if there is stable uncemented femoral component in revi